Latest Sutro Biopharma Stories
SAN FRANCISCO, Sept.
Collaboration to Express Antibodies and Antigens based on Sutro's Technology Platform Xpress CF(TM) SAN FRANCISCO, Sept.
SAN FRANCISCO, March 24, 2014 /PRNewswire/ -- Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates
SAN FRANCISCO, Jan.
- Growing in low tufty patches.